All In MedTech

Device Trial Radar · NCT03238274

Sofia 2 Lyme FIA Whole Blood Clinical Study

Last checked: Nov 19, 2026Latest source record: Mar 20, 2018 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

597

Actual

Start

Jun 6, 2017

Primary completion

Dec 15, 2017

Study completion Dec 15, 2017

Sponsor

Lead sponsor
Quidel CorporationNot on our public-company list
Sponsor type
Industry
First posted
Aug 3, 2017

More device trials from this sponsor

Design

Study type
Observational
FDA-regulated device
Yes
Who can join
All sexes, from 1 year
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The objective of this study is to demonstrate the clinical performance of the Sofia® 2 analyzer and Sofia Lyme FIA test in the CLIA waived test environment in comparison to Comparator Method(s) and/or an FDA cleared predicate test(s) using matched finger-stick, whole blood and serum from symptomatic subjects.

Conditions

  • Borrelia; Infection, Burgdorferi (Erythema Chronicum Migrans)

Interventions

  • Sofia 2 Lyme FIA testingDevice

    IVD testing of whole blood or serum/plasma to aid in the detection of anti-B. burgdorferi IgG / IgM antibody

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Detection of anti-B. burgdorferi IgG / IgM antibodyTime frame: 15 minutes

Locations

11 sites in 1 country. Site status is shown where the registry gives one.

  • NECCR Primacare Research, LLC

    Fall River, Massachusetts

  • Main Road Family Medicine

    South Westport, Massachusetts

  • Essentia Institute of Rural Health

    Duluth, Minnesota

8 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.